Fruquitinib Combined With Camrelizumab in Non MSI-H/dMMR Refractory Colorectal Cancer

Name: Fruquitinib Combined With Camrelizumab in Non MSI-H/dMMR Refractory Colorectal Cancer
License: Public Domain

The First Affiliated Hospital with Nanjing Medical University

ClinicalTrials.gov · Datasets · License: Public Domain

colorectal neoplasm

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 623524
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.